Cancer cases have increased by more than 30 percent in the last decade and half of all cases globally are ending up in deaths according to a new report from the Global Burden of Disease Cancer Collaboration published online by JAMA Oncology. Moreover, the overall contribution of cytotoxic chemotherapy to 5-year survival in adults is below 3 percent.
Cancers figure among the leading causes of morbidity and mortality worldwide. Between 2005 and 2015, cancer cases increased by 33 percent and the number of new cases is expected to rise by about 70% over the next just two decades under the current global disease promoting paradigm.
Cancer is part of the conglomerate of preventable disease which makes up approximately 80% percent of the burden of illness and 90% of all healthcare costs.
The report by Christina Fitzmaurice, M.D., M.P.H., of the University of Washington, Seattle and coauthors estimated cancer deaths using vital registration system data, cancer registry incidence data and verbal autopsy data.
Other key findings from the report were:
Globally, the odds of developing cancer during a lifetime were 1 in 3 for men and 1 in 4 for women.
Prostate cancer was the most common cancer globally in men (1.6 million cases); tracheal, bronchus and lung (TBL) cancer was the leading cause of cancer deaths for men.
Breast cancer was the most common cancer for women (2.4 million cases) and the leading cause of cancer deaths in women.
The most common childhood cancers were leukemia, other neoplasms, non-Hodgkin lymphoma, and brain and nervous system cancers.
“Semblance is all about illusion,” says oncologist Dr. Maven Rowland. “We given a false appearance of what cancer is and how we can treat it and unfortunately we do not have a detailed understanding from a medical perspective of cancer burden or how to treat its growing incidence in the global epidemiological and demographic transition.”
Part of the failure in treating cancer is our reliance on cytotoxic drugs, especially conventional chemotherapy used broadly across the world. As more people abstain from using chemotherapy as a treatment for cancer, more people are surviving.
Why Chemotherapy Makes Cancer Worse
A 14-year study published in the Journal of Clinical Oncology in December 2004 called “The Contribution of Cytotoxic Chemotherapy to 5-year Survival in Adult Malignancies” showed that the overall contribution of curative and adjuvant cytotoxic chemotherapy to 5-year survival in adults was estimated to be 2.3% in Australia and 2.1 % in The USA.
Oncologists recommend cytotoxic chemotherapy for most patients in for the palliation of symptoms and to and to improve quality of life. It is aims at improving survival. None of the above has materialized as truth for the cancer industry since the inception of the treatment and despite the use of new and expensive single and combination drugs to improve response rates and other agents to allow for dose escalation, there has been no change for the regimens used.